Snake envenomation has been declared a neglected tropical disease by the World Health Organization, with up to 5 million snakebite incidents globally, of which 3.75 million people are severely affected, resulting in 1.25 million deaths annually (Warrell, 2010; Williams et al., 2010). In large part, this high burden results from frequent encounters between the growing human and snake populations, under-developed healthcare systems, and minimal access to relevant antivenoms.
